North America Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Type Of Synthesis (Biotech, Synthetic), By Type Of Manufacturer (Captive, Mesrchant), By Type, By Application, By Type Of Drug, By Country, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation
                        1.1.1. Market Definitions
                    1.2. Objectives
                        1.2.1. Objective - 1
                        1.2.2. Objective - 2
                        1.2.3. Objective - 3
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased Database
                        1.4.2. Gvr’s Internal Database
                        1.4.3. Secondary Sources
                        1.4.4. Primary Research
                    1.5. Information or Data Analysis
                        1.5.1. Data Analysis Models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity Flow Analysis
                    1.8. List of Secondary Sources
                    1.9. List of Abbreviations
                    1.10. List of Primary Sources
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. North America Active Pharmaceutical Ingredients Market Variables, Trends, & Scope
                    3.1. Market Segmentation and Scope
                    3.2. Market Lineage Outlook
                        3.2.1. Parent Market Outlook
                        3.2.2. Related/Ancillary Market Outlook
                    3.3. Market Dynamics
                    3.4. Market Drivers
                        3.4.1. Increasing geriatric population
                        3.4.2. Rising prevalence of target diseases such as hospital-acquired infections, genetic, cardiovascular, and neurological diseases
                        3.4.3. Increasing preference for targeted therapy approach in cancer treatment
                        3.4.4. Increasing preference for outsourcing APIs
                    3.5. Market Restraint Analysis
                        3.5.1. High capital investments and production cost
                        3.5.2. Stringent Safety and handling regulations regarding APIs
                    3.6. Business Environment Analysis
                        3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
                        3.6.2. Porter’s Five Forces Analysis
                        3.6.3. COVID-19 Impact Analysis
Chapter 4. North America Active Pharmaceutical Ingredients Market: Type of Synthesis Estimates & Trend Analysis
                    4.1. North America Active Pharmaceutical Ingredients Market: Type of Synthesis Segment Dashboard
                    4.2. North America Active Pharmaceutical Ingredients Market: Type of Synthesis Movement Analysis
                    4.3. North America Active Pharmaceutical Ingredients Market Size & Trend Analysis, by Type of Synthesis, 2018 to 2030 (USD Billion)
                    4.4. Biotic APIs
                        4.4.1. Biotic APIs Market, 2018 - 2030 (USD Billion)
                            4.4.1.1. Biotech APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)
                            4.4.1.2. Generic APIs
                                4.4.1.2.1. Generic APIs Market, 2018 - 2030 (USD Billion)
                            4.4.1.3. Innovative APIs
                                4.4.1.3.1. Innovative APIs Market, 2018 - 2030 (USD Billion)
                            4.4.1.4. Biotech APIs Market, By Product (Revenue, USD Billion, 2018 - 2030)
                            4.4.1.5. Monoclonal Antibodies
                                4.4.1.5.1. Monoclonal Antibodies Market, 2018 - 2030 (USD Billion)
                            4.4.1.6. Hormones
                                4.4.1.6.1. Hormones Market, 2018 - 2030 (USD Billion)
                            4.4.1.7. Cytokines
                                4.4.1.7.1. Cytokines Market, 2018 - 2030 (USD Billion)
                            4.4.1.8. Recombinant Proteins
                                4.4.1.8.1. Recombinant Proteins Market, 2018 - 2030 (USD Billion)
                            4.4.1.9. Therapeutic Enzymes
                                4.4.1.9.1. Therapeutic Enzymes Market, 2018 - 2030 (USD Billion)
                            4.4.1.10. Vaccines
                                4.4.1.10.1. Vaccines Market, 2018 - 2030 (USD Billion)
                            4.4.1.11. Blood Factors
                                4.4.1.11.1. Blood Factors Market, 2018 - 2030 (USD Billion)
                    4.5. Synthetic APIs
                        4.5.1. Synthetic APIs Market, 2018 - 2030 (USD Billion)
                            4.5.1.1. Synthetic APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)
                            4.5.1.2. Generic APIs
                                4.5.1.2.1. Generic APIs Market, 2018 - 2030 (USD Billion)
                            4.5.1.3. Innovative APIs
                                4.5.1.3.1. Innovative APIs Market, 2018 - 2030 (USD Billion)
Chapter 5. North America Active Pharmaceutical Ingredients Market: Type of Manufacturer Estimates & Trend Analysis
                    5.1. North America Active Pharmaceutical Ingredients Market: Type of Manufacturer, Segment Dashboard
                    5.2. North America Active Pharmaceutical Ingredients Market: Type of Manufacturer, Movement Analysis
                    5.3. North America Active Pharmaceutical Ingredients Market Size & Trend Analysis, by Type of Manufacturer, 2018 to 2030 (USD Billion)
                    5.4. Captive APIs
                        5.4.1. Captive APIs Market, 2018 - 2030 (USD Billion)
                    5.5. Merchant APIs
                        5.5.1. Merchant APIs Market, 2018 - 2030 (USD Billion)
Chapter 6. North America Active Pharmaceutical Ingredients Market: Type Estimates & Trend Analysis
                    6.1. North America Active Pharmaceutical Ingredients Market: Type Segment Dashboard
                    6.2. North America Active Pharmaceutical Ingredients Market: Type Movement Analysis
                    6.3. North America Active Pharmaceutical Ingredients Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Billion)
                    6.4. Generic APIs
                        6.4.1. Generic APIs Market, 2018 - 2030 (USD Billion)
                    6.5. Innovative APIs
                        6.5.1. Innovative APIs Market, 2018 - 2030 (USD Billion)
Chapter 7. North America Active Pharmaceutical Ingredients Market: Application Estimates & Trend Analysis
                    7.1. North America Active Pharmaceutical Ingredients Market: Application Segment Dashboard
                    7.2. North America Active Pharmaceutical Ingredients Market: Application Movement Analysis
                    7.3. North America Active Pharmaceutical Ingredients Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Billion)
                    7.4. Cardiovascular Diseases
                        7.4.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Billion)
                    7.5. Oncology
                        7.5.1. Innovative APIs Oncology Market, 2018 - 2030 (USD Billion)
                    7.6. CNS and Neurology
                        7.6.1. CNS and Neurology Market, 2018 - 2030 (USD Billion)
                    7.7. Orthopedic
                        7.7.1. Orthopedic Market, 2018 - 2030 (USD Billion)
                    7.8. Endocrinology
                        7.8.1. Endocrinology Market, 2018 - 2030 (USD Billion)
                    7.9. Pulmonology
                        7.9.1. Pulmonology Market, 2018 - 2030 (USD Billion)
                    7.10. Gastroenterology
                        7.10.1. Gastroenterology Market, 2018 - 2030 (USD Billion)
                    7.11. Nephrology
                        7.11.1. Nephrology Market, 2018 - 2030 (USD Billion)
                    7.12. Ophthalmology
                        7.12.1. Ophthalmology Market, 2018 - 2030 (USD Billion)
                    7.13. Others
                        7.13.1. Others Market, 2018 - 2030 (USD Billion)
Chapter 8. North America Active Pharmaceutical Ingredients Market: Type of Drug Estimates & Trend Analysis
                    8.1. North America Active Pharmaceutical Ingredients Market: Type of Drug Segment Dashboard
                    8.2. North America Active Pharmaceutical Ingredients Market: Type of Drug Movement Analysis
                    8.3. North America Active Pharmaceutical Ingredients Market Size & Trend Analysis, by Type of Drug, 2018 to 2030 (USD Billion)
                    8.4. Prescription
                        8.4.1. Prescription Market, 2018 - 2030 (USD Billion)
                            8.4.1.1. OTC
                            8.4.1.2. OTC Market, 2018 - 2030 (USD Billion)
Chapter 9. North America Active Pharmaceutical Ingredients Market: Country Estimates & Trend Analysis
                    9.1. Active Pharmaceutical Ingredients Market Share By Region, 2023 & 2030
                    9.2. North America
                        9.2.1. North America Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.2.2. U.S.
                            9.2.2.1. Key Country Dynamics
                            9.2.2.2. Target Disease Prevalence
                            9.2.2.3. Competitive Scenario
                            9.2.2.4. Regulatory Framework
                            9.2.2.5. Reimbursement Scenario
                            9.2.2.6. U.S. Active pharmaceutical ingredients market, 2018 - 2030 (USD Million)
                        9.2.3. Canada
                            9.2.3.1. Key Country Dynamics
                            9.2.3.2. Target Disease Prevalence
                            9.2.3.3. Competitive Scenario
                            9.2.3.4. Regulatory Framework
                            9.2.3.5. Reimbursement Scenario
                            9.2.3.6. Canada Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Chapter 10. Competitive Landscape
                    10.1. Participant’s overview
                    10.2. Financial performance
                    10.3. Participant categorization
                        10.3.1. Market Leaders
                        10.3.2. Active Pharmaceutical Ingredients Market Share Analysis, 2023
                        10.3.3. Company Profiles
                            10.3.3.1. Dr. Reddy’s Laboratories Ltd.
                                10.3.3.1.1. Company Overview
                                10.3.3.1.2. Financial Performance
                                10.3.3.1.3. Product Benchmarking
                                10.3.3.1.4. Strategic Initiatives
                            10.3.3.2. Sun Pharmaceutical Industries Ltd.
                                10.3.3.2.1. Company Overview
                                10.3.3.2.2. Financial Performance
                                10.3.3.2.3. Product Benchmarking
                                10.3.3.2.4. Strategic Initiatives
                            10.3.3.3. Teva Pharmaceutical Industries Ltd.
                                10.3.3.3.1. Company Overview
                                10.3.3.3.2. Financial Performance
                                10.3.3.3.3. Product Benchmarking
                                10.3.3.3.4. Strategic Initiatives
                            10.3.3.4. Cipla Inc.
                                10.3.3.4.1. Company Overview
                                10.3.3.4.2. Financial Performance
                                10.3.3.4.3. Product Benchmarking
                                10.3.3.4.4. Strategic Initiatives
                            10.3.3.5. AbbVie Inc.
                                10.3.3.5.1. Company Overview
                                10.3.3.5.2. Financial Performance
                                10.3.3.5.3. Product Benchmarking
                                10.3.3.5.4. Strategic Initiatives
                            10.3.3.6. Aurobindo Pharma
                                10.3.3.6.1. Company Overview
                                10.3.3.6.2. Financial Performance
                                10.3.3.6.3. Product Benchmarking
                                10.3.3.6.4. Strategic Initiatives
                            10.3.3.7. Sandoz International GmbH (Novartis AG)
                                10.3.3.7.1. Company Overview
                                10.3.3.7.2. Financial Performance
                                10.3.3.7.3. Product Benchmarking
                                10.3.3.7.4. Strategic Initiatives
                            10.3.3.8. Viatris Inc.
                                10.3.3.8.1. Company Overview
                                10.3.3.8.2. Financial Performance
                                10.3.3.8.3. Product Benchmarking
                                10.3.3.8.4. Strategic Initiatives
                            10.3.3.9. Fresenius Kabi AG
                                10.3.3.9.1. Company Overview
                                10.3.3.9.2. Financial Performance
                                10.3.3.9.3. Product Benchmarking
                                10.3.3.9.4. Strategic Initiatives
                            10.3.3.10. STADA Arzneimittel AG
                                10.3.3.10.1. Company Overview
                                10.3.3.10.2. Financial Performance
                                10.3.3.10.3. Product Benchmarking
                                10.3.3.10.4. Strategic Initiatives
                            10.3.3.11. Lonza
                                10.3.3.11.1. Company Overview
                                10.3.3.11.2. Financial Performance
                                10.3.3.11.3. Product Benchmarking
                                10.3.3.11.4. Strategic Initiatives
                            10.3.3.12. Curia
                                10.3.3.12.1. Company Overview
                                10.3.3.12.2. Financial Performance
                                10.3.3.12.3. Product Benchmarking
                                10.3.3.12.4. Strategic Initiatives
                            10.3.3.13. Pfizer Inc.
                                10.3.3.13.1. Company Overview
                                10.3.3.13.2. Financial Performance
                                10.3.3.13.3. Product Benchmarking
                                10.3.3.13.4. Strategic Initiatives
                            10.3.3.14. Bristol-Myers Squibb Company
                                10.3.3.14.1. Company Overview
                                10.3.3.14.2. Financial Performance
                                10.3.3.14.3. Product Benchmarking
                                10.3.3.14.4. Strategic Initiatives
                            10.3.3.15. Merck KGaA
                                10.3.3.15.1. Company Overview
                                10.3.3.15.2. Financial Performance
                                10.3.3.15.3. Product Benchmarking
                                10.3.3.15.4. Strategic Initiatives
                            10.3.3.16. Catalent, Inc.
                                10.3.3.16.1. Company Overview
                                10.3.3.16.2. Financial Performance
                                10.3.3.16.3. Product Benchmarking
                                10.3.3.16.4. Strategic Initiatives
                        10.3.4. Strategy Mapping
                            10.3.4.1. Expansion
                            10.3.4.2. Acquisition
                            10.3.4.3. Collaborations
                            10.3.4.4. Disease Type/Drug Class Launch
                            10.3.4.5. Partnerships
                            10.3.4.6. Others

List of Tables

Table 1 List of Tables
Table 2 North America Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
Table 3 North America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 4 North America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 5 North America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 6 North America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 7 North America Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 8 U.S. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 9 U.S. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 10 U.S. Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 11 U.S. Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 12 U.S. Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 13 Canada Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 14 Canada Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 15 Canada Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 16 Canada Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 17 Canada Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Active pharmaceutical ingredients market segmentation
Fig. 8 Market driver relevance analysis (Current & future impact)
Fig. 9 Market restraint relevance analysis (Current & future impact)
Fig. 10 Market challenge relevance analysis (Current & future impact)
Fig. 11 Penetration & growth prospect mapping
Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 13 Porter’s Five Forces analysis
Fig. 14 Market penetration vs growth prospect mapping
Fig. 15 Active pharmaceutical ingredients market: Type of synthesis movement analysis
Fig. 16 Biotech APIs market, 2018 - 2030 (USD Billion)
Fig. 17 Synthetic APIs market, 2018 - 2030 (USD Billion)
Fig. 18 Active pharmaceutical ingredients market: Type of manufacturer movement analysis
Fig. 19 Captive APIs market, 2018 - 2030 (USD Billion)
Fig. 20 Merchant APIs market, 2018 - 2030 (USD Billion)
Fig. 21 Active pharmaceutical ingredients market: Type movement analysis
Fig. 22 Generic APIs market, 2018 - 2030 (USD Billion)
Fig. 23 Innovative APIs market, 2018 - 2030 (USD Billion)
Fig. 24 Active pharmaceutical ingredients market: Application movement analysis
Fig. 25 Cardiovascular diseases market, 2018 - 2030 (USD Billion)
Fig. 26 Oncology market, 2018 - 2030 (USD Billion)
Fig. 27 CNS and Neurology market, 2018 - 2030 (USD Billion)
Fig. 28 Orthopaedic market, 2018 - 2030 (USD Billion)
Fig. 29 Endocrinology market, 2018 - 2030 (USD Billion)
Fig. 30 Pulmonology market, 2018 - 2030 (USD Billion)
Fig. 31 Gastroenterology market, 2018 - 2030 (USD Billion)
Fig. 32 Nephrology market, 2018 - 2030 (USD Billion)
Fig. 33 Ophthalmology market, 2018 - 2030 (USD Billion)
Fig. 34 Others market, 2018 - 2030 (USD Billion)
Fig. 35 Active pharmaceutical ingredients market: Type of drug movement analysis
Fig. 36 Prescription market, 2018 - 2030 (USD Billion)
Fig. 37 OTC market, 2018 - 2030 (USD Billion)
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 Regional outlook, 2018 & 2030
Fig. 40 North America active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 41 U.S. active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 42 Canada active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)